價(jià)格 | ¥397 | ¥788 | ¥997 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱:化合物 PF-06424439 methanesulfonate | 英文名稱:PF-06424439 methanesulfonate |
CAS:1469284-79-4 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.77% | 產(chǎn)品類(lèi)別: 抑制劑 |
貨號(hào): T12425 |
名稱 | PF-06424439 methanesulfonate |
描述 | PF-06424439 methanesulfonate, an orally administered, potent, and selective imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitor with an IC50 of 14 nM, demonstrates slow reversibility and time-dependent inhibition. It operates in a noncompetitive manner relative to the acyl-CoA substrate, marking its efficacy in targeting DGAT2. |
動(dòng)物實(shí)驗(yàn) | PF-06424439 methanesulfonate (i.v.; 1 mg/kg) shows moderate clearance in rats following intravenous administration and moderate steady-state volume of distribution (Vdss) results in a short half-life[1].PF-06424439 methanesulfonate (p.o.; 60 mg/kg/day; for 3 days) reduces plasma TG and cholesterol levels and decreases nonsignificant in circulating lipids in mice (Ldlr-/-)[1]. |
體內(nèi)活性 | PF-06424439 methanesulfonate shows moderate clearance in rats following intravenous administration and moderate steady-state volume of distribution (Vdss) results in a short half-life[1]. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 249 mg/mL (464.50 mM), Sonication is recommended. H2O : 99 mg/mL (184.68 mM) |
關(guān)鍵字 | acyl-CoA:cholesterol acyltransferase | Inhibitor | Acyltransferase | mono- acylglycerol acyltransferase | PF-06424439 | PF 06424439 methanesulfonate | inhibit | Diacylglycerol acyltransferase | PF06424439 | Diglyceride acyltransferase | PF06424439 methanesulfonate | PF 06424439 | PF-06424439 methanesulfonate |
相關(guān)產(chǎn)品 | Alendronate sodium hydrate | Entacapone | 2-Furoic acid | Risedronic Acid | YM17E | 3-Methoxybenzamide | Minodronic acid monohydrate | Cyclandelate | Serotonin hydrochloride | Flopropione | Testosterone propionate | Ibandronate sodium |
相關(guān)庫(kù) | 抑制劑庫(kù) | 脂代謝化合物庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 代謝化合物庫(kù) | NO PAINS 化合物庫(kù) | 抗肥胖化合物庫(kù) | 口服活性化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP2年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-07-24 | |
詢價(jià) |
VIP3年
|
鄭州匯聚化工有限公司
|
2024-11-08 | |
詢價(jià) |
VIP3年
|
武漢英諾醫(yī)藥科技有限公司
|
2024-11-07 | |
¥1380.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2024-10-31 |